ACOUSIA THERAPEUTICS
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss. Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells. ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity.
ACOUSIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Tübingen, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.acousia.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
14.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Catapult Therapeutics
Catapult Therapeutics is a privately held Dutch biotech company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Gubra
Gubra is a privately-held biotech company
ICD Therapeutics
ICD Therapeutics is a privately held MacroDel biologics-delivery platform developer.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Acousia Therapeutics
LBBW VC
LBBW VC investment in Series B - Acousia Therapeutics
Creathor Ventures
Creathor Ventures investment in Series B - Acousia Therapeutics
Bregua Corporation
Bregua Corporation investment in Series B - Acousia Therapeutics
KfW
KfW investment in Series B - Acousia Therapeutics
Axxam
Axxam investment in Series A - Acousia Therapeutics
KfW
KfW investment in Series A - Acousia Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Acousia Therapeutics
Official Site Inspections
http://www.acousia.com
- Host name: 185.243.133.181
- IP address: 185.243.133.181
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin